201 related articles for article (PubMed ID: 12011534)
1. Antimicrobial effectiveness of povidone-iodine and consequences for new application areas.
Reimer K; Wichelhaus TA; Schäfer V; Rudolph P; Kramer A; Wutzler P; Ganzer D; Fleischer W
Dermatology; 2002; 204 Suppl 1():114-20. PubMed ID: 12011534
[TBL] [Abstract][Full Text] [Related]
2. [Antibacterial effectiveness of povidone-iodine (Betaisodona) against highly resistance gram positive organisms].
Wichelhaus TA; Schäfer V; Hunfeld KP; Reimer K; Fleischer W; Brade V
Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):435-42. PubMed ID: 9531717
[TBL] [Abstract][Full Text] [Related]
3. Povidone-iodine in antisepsis--state of the art.
Fleischer W; Reimer K
Dermatology; 1997; 195 Suppl 2():3-9. PubMed ID: 9403248
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test.
Block C; Robenshtok E; Simhon A; Shapiro M
J Hosp Infect; 2000 Oct; 46(2):147-52. PubMed ID: 11049709
[TBL] [Abstract][Full Text] [Related]
5. New aspects of the tolerance of the antiseptic povidone-iodine in different ex vivo models.
Kramer A; Below H; Behrens-Baumann W; Müller G; Rudolph P; Reimer K
Dermatology; 2002; 204 Suppl 1():86-91. PubMed ID: 12011528
[TBL] [Abstract][Full Text] [Related]
6. Iodine-lithium-alpha-dextrin (ILαD) against Staphylococcus aureus skin infections: a comparative study of in-vitro bactericidal activity and cytotoxicity between ILαD and povidone-iodine.
Zisi AP; Exindari MK; Siska EK; Koliakos GG
J Hosp Infect; 2018 Feb; 98(2):134-140. PubMed ID: 28736269
[TBL] [Abstract][Full Text] [Related]
7. The management of methicillin-resistant Staphylococcus aureus in a major hospital.
Tyzack R
J Hosp Infect; 1985 Mar; 6 Suppl A():195-9. PubMed ID: 2860168
[TBL] [Abstract][Full Text] [Related]
8. In vitro efficacy of povidone-iodine solution and cream against methicillin-resistant Staphylococcus aureus.
Goldenheim PD
Postgrad Med J; 1993; 69 Suppl 3():S62-5. PubMed ID: 8290460
[TBL] [Abstract][Full Text] [Related]
9. Novel antiseptic compound OPB-2045G shows potent bactericidal activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus both in vitro and in vivo: a pilot study in animals.
Inoue Y; Hagi A; Nii T; Tsubotani Y; Nakata H; Iwata K
J Med Microbiol; 2015 Jan; 64(Pt 1):32-36. PubMed ID: 25351713
[TBL] [Abstract][Full Text] [Related]
10. Investigation on the efficacy of povidone-iodine against antiseptic-resistant species.
Kunisada T; Yamada K; Oda S; Hara O
Dermatology; 1997; 195 Suppl 2():14-8. PubMed ID: 9403250
[TBL] [Abstract][Full Text] [Related]
11. Gargling with povidone-iodine reduces the transport of bacteria during oral intubation.
Ogata J; Minami K; Miyamoto H; Horishita T; Ogawa M; Sata T; Taniguchi H
Can J Anaesth; 2004 Nov; 51(9):932-6. PubMed ID: 15525622
[TBL] [Abstract][Full Text] [Related]
12. In-vitro evaluation of povidone-iodine and chlorhexidine against methicillin-resistant Staphylococcus aureus.
McLure AR; Gordon J
J Hosp Infect; 1992 Aug; 21(4):291-9. PubMed ID: 1355784
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus.
Haley CE; Marling-Cason M; Smith JW; Luby JP; Mackowiak PA
J Clin Microbiol; 1985 Jun; 21(6):991-2. PubMed ID: 4008627
[TBL] [Abstract][Full Text] [Related]
14. Povidone-iodine liposomes--an overview.
Reimer K; Fleischer W; Brögmann B; Schreier H; Burkhard P; Lanzendörfer A; Gümbel H; Hoekstra H; Behrens-Baumann W
Dermatology; 1997; 195 Suppl 2():93-9. PubMed ID: 9403264
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of 3 cutaneous/mucosal antiseptic solutions in the presence of interfering substances: Improvement of the NF EN 13727 European Standard?
Salvatico S; Feuillolay C; Mas Y; Verrière F; Roques C
Med Mal Infect; 2015 Mar; 45(3):89-94. PubMed ID: 25779009
[TBL] [Abstract][Full Text] [Related]
16. The in-vitro activity of povidone-iodinecream against Staphylococcus aureus and its bioavailability in nasal secretions.
Hill RL; Casewell MW
J Hosp Infect; 2000 Jul; 45(3):198-205. PubMed ID: 10896798
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in UK hospitals and the relevance of povidone-iodine in their control.
Gordon J
Postgrad Med J; 1993; 69 Suppl 3():S106-16. PubMed ID: 8290446
[TBL] [Abstract][Full Text] [Related]
18. Impact of alcohol-based, waterless hand antiseptic on the incidence of infection and colonization with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Lai KK; Fontecchio S; Melvin Z; Baker SP
Infect Control Hosp Epidemiol; 2006 Oct; 27(10):1018-24. PubMed ID: 17006807
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Staphylococcus aureus including MRSA to four disinfectants.
Suzuki J; Komatsuzawa H; Kozai K; Nagasaka N
ASDC J Dent Child; 1997; 64(4):260-3. PubMed ID: 9328677
[TBL] [Abstract][Full Text] [Related]
20. [Effects of antiseptics against methicillin-resistant Staphylococcus aureus].
Watanabe Y; Nawa H; Koike N
Kansenshogaku Zasshi; 1995 Nov; 69(11):1235-43. PubMed ID: 8708403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
